Brief: Nordic Nanovector Completes Patient Enrolment In Phase 1 Trial Of Betalutin In Diffuse Large B-Cell Lymphoma

Thor Medical ASA

11/07/2019 14:24

July 11 (Reuters) - Nordic Nanovector ASA  NANOV.OL :
    * NORDIC NANOVECTOR COMPLETES PATIENT ENROLMENT INTO PHASE 1
TRIAL
OF BETALUTIN® IN DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL)
    * NORDIC NANOVECTOR ASA - PRELIMINARY RESULTS ARE EXPECTED
IN
SECOND HALF OF 2019

Source text for Eikon:  ID:nPn2mhFcNa 
Further company coverage:  NANOV.OL 

 ((Reuters.Briefs@thomsonreuters.com;))